Literature DB >> 30119667

Correction to: Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.

Maayan Waldman1,2, Keren Cohen1,2, Dor Yadin1,2, Vadim Nudelman1, Dan Gorfil1, Michal Laniado-Schwartzman3, Ran Kornwoski1, Dan Aravot1, Nader G Abraham3, Michael Arad2, Edith Hochhauser4,5.   

Abstract

Unfortunately, after publication of this article [1], it was noticed that Table 1 contained errors introduced during the production process. In the WT + AT column, the FS value is 21 ± 7 and the Body Weight value is 25 ± 2. In the WT + AT + CR column, the FS value is 46 ± 14 and the Body Weight value is 19 ± 1. The original article has been updated to reflect this.

Entities:  

Year:  2018        PMID: 30119667      PMCID: PMC6097296          DOI: 10.1186/s12933-018-0757-1

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


Correction to: Cardiovasc Diabetol (2018) 17:111 10.1186/s12933-018-0754-4

Unfortunately, after publication of this article [1], it was noticed that Table 1 contained errors introduced during the production process. In the WT + AT column, the value for the FS row is 21 ± 7 and the value for the Body Weight row is 25 ± 2. In the WT + AT + CR column, the value for the FS row is 46 ± 14 and the value for the Body Weight row is 19 ± 1. The original article has been corrected.
  1 in total

1.  Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.

Authors:  Maayan Waldman; Keren Cohen; Dor Yadin; Vadim Nudelman; Dan Gorfil; Michal Laniado-Schwartzman; Ran Kornwoski; Dan Aravot; Nader G Abraham; Michael Arad; Edith Hochhauser
Journal:  Cardiovasc Diabetol       Date:  2018-08-02       Impact factor: 9.951

  1 in total
  1 in total

1.  Perindopril Improves Cardiac Function by Enhancing the Expression of SIRT3 and PGC-1α in a Rat Model of Isoproterenol-Induced Cardiomyopathy.

Authors:  Zhenyu Zhu; Huihui Li; Wanli Chen; Yameng Cui; Anan Huang; Xin Qi
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.